Ahn SH

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : Preclinical Development of PNT6555, a Boronic Acid-Based, Fibroblast Activation Protein-alpha (FAP)-Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors - Poplawski_2023_J.Nucl.Med__
Author(s) : Poplawski SE , Hallett RM , Dornan MH , Novakowski KE , Pan S , Belanger AP , Nguyen QD , Wu W , Felten AE , Liu Y , Ahn SH , Hergott VS , Jones B , Lai JH , McCann JAB , Bachovchin WW
Ref : J Nucl Med , : , 2023
Abstract : Poplawski_2023_J.Nucl.Med__
ESTHER : Poplawski_2023_J.Nucl.Med__
PubMedSearch : Poplawski_2023_J.Nucl.Med__
PubMedID: 38050111

Title : Pharmacokinetics and safety of evogliptin in hepatically impaired patients - Hong_2021_Br.J.Clin.Pharmacol_87_2757
Author(s) : Hong T , Jin BH , Kim CO , Yoo BW , Kim D , Lee JI , Kim BK , Ahn SH , Kim DY , Park JY , Park MS
Ref : British Journal of Clinical Pharmacology , 87 :2757 , 2021
Abstract : Hong_2021_Br.J.Clin.Pharmacol_87_2757
ESTHER : Hong_2021_Br.J.Clin.Pharmacol_87_2757
PubMedSearch : Hong_2021_Br.J.Clin.Pharmacol_87_2757
PubMedID: 33245796

Title : Drug persistency of cholinesterase inhibitors for patients with dementia of Alzheimer type in Korea - Ahn_2015_Arch.Pharm.Res_38_1255
Author(s) : Ahn SH , Choi NK , Kim YJ , Seong JM , Shin JY , Jung SY , Park BJ
Ref : Arch Pharm Res , 38 :1255 , 2015
Abstract : Ahn_2015_Arch.Pharm.Res_38_1255
ESTHER : Ahn_2015_Arch.Pharm.Res_38_1255
PubMedSearch : Ahn_2015_Arch.Pharm.Res_38_1255
PubMedID: 25336105

Title : Mechanism for increased bioavailability of tacrine in fasted rats - Sung_2006_J.Pharm.Pharmacol_58_643
Author(s) : Sung JH , Hong SS , Ahn SH , Li H , Seo SY , Park CH , Park BS , Chung SJ
Ref : J Pharm Pharmacol , 58 :643 , 2006
Abstract : Sung_2006_J.Pharm.Pharmacol_58_643
ESTHER : Sung_2006_J.Pharm.Pharmacol_58_643
PubMedSearch : Sung_2006_J.Pharm.Pharmacol_58_643
PubMedID: 16640833